- Home
- III vs CMPX Comparison
III vs CMPX Comparison
Compare III & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- III
- CMPX
- Stock Information
- Founded
- III 2006
- CMPX 2014
- Country
- III United States
- CMPX United States
- Employees
- III N/A
- CMPX N/A
- Industry
- III Professional Services
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- III Consumer Discretionary
- CMPX Health Care
- Exchange
- III Nasdaq
- CMPX Nasdaq
- Market Cap
- III 147.5M
- CMPX 217.4M
- IPO Year
- III 2007
- CMPX N/A
- Fundamental
- Price
- III $3.16
- CMPX $1.43
- Analyst Decision
- III Buy
- CMPX Strong Buy
- Analyst Count
- III 1
- CMPX 2
- Target Price
- III $3.50
- CMPX $9.00
- AVG Volume (30 Days)
- III 68.0K
- CMPX 429.9K
- Earning Date
- III 10-31-2024
- CMPX 08-12-2024
- Dividend Yield
- III 5.70%
- CMPX N/A
- EPS Growth
- III N/A
- CMPX N/A
- EPS
- III N/A
- CMPX N/A
- Revenue
- III $266,491,000.00
- CMPX $850,000.00
- Revenue This Year
- III N/A
- CMPX N/A
- Revenue Next Year
- III $11.73
- CMPX $950.68
- P/E Ratio
- III N/A
- CMPX N/A
- Revenue Growth
- III N/A
- CMPX N/A
- 52 Week Low
- III $2.92
- CMPX $0.77
- 52 Week High
- III $4.98
- CMPX $2.34
- Technical
- Relative Strength Index (RSI)
- III 40.52
- CMPX 60.03
- Support Level
- III $3.15
- CMPX $1.19
- Resistance Level
- III $3.53
- CMPX $1.61
- Average True Range (ATR)
- III 0.11
- CMPX 0.10
- MACD
- III -0.02
- CMPX 0.02
- Stochastic Oscillator
- III 15.91
- CMPX 43.34
About III Information Services Group Inc.
Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.